STAT News

MARCH 30, 2023

Supreme Court to review a controversy over so-called skinny labels for medicines, arguing that an appeals court finding threatens the availability of lower-cost generic drugs. For instance, a generic drug could be marketed to treat one type of heart problem, but not another.

Generic Drugs 111

Generic Drugs Drugs Branding Medicine 111

Bio Pharma Dive

OCTOBER 26, 2021

The generic drug unit has struggled in recent years, while Novartis has moved to focus more narrowly on higher-margin branded medicines.

Generic Drugs 182

Generic Drugs Sales Branding Medicine 182

Drug Patent Watch

DECEMBER 11, 2024

Generic drugs play a crucial role in providing affordable healthcare options to millions of patients worldwide. One of the key tools that generic drug manufacturers rely on to navigate the complex regulatory environment is the FDA’s Product Specific Guidances (PSGs). ” – Dr.

Generic Drugs 95

Generic Drugs Production Development Bioequivalency 95

Drug Patent Watch

DECEMBER 30, 2024

The regulatory environment in Japan for generic drug development is complex and has undergone significant changes in recent years. Abbreviated New Drug Application (ANDA) : Required for marketing approval of generic drugs. Regulatory System on Generic Drugs in Japan.

Generic Drugs 52

Generic Drugs Bioequivalency Development Drugs 52

Drug Patent Watch

JANUARY 23, 2025

The Future of Generic Drug Development: Opportunities and Challenges for Emerging Markets As the global healthcare landscape continues to evolve, emerging markets are playing an increasingly important role in shaping the future of generic drug development. Share your thoughts in the comments below!

Generic Drugs 52

Generic Drugs Marketing Development Drugs 52

Drug Patent Watch

JANUARY 14, 2025

The Generic Drug Revolution: Setting the Stage Before we dive into the nitty-gritty, let’s take a moment to appreciate the impact of generic drugs. Why Generic Drugs Matter Generic drugs are the Robin Hoods of the pharmaceutical world, stealing from the rich (brand-name drugs) and giving to the poor (our wallets).

Generic Drugs 52

Generic Drugs Development Drugs Manufacturing 52

Drug Patent Watch

NOVEMBER 18, 2024

This growth is driven by several factors, including the increasing prevalence of chronic diseases, cost-effectiveness, and patent expirations of branded drugs. The future of generic drug development in emerging markets looks promising, with technological advancements… Source

Generic Drugs 98

Generic Drugs Marketing Development Drugs 98

Pharmacy Checkers

FEBRUARY 5, 2021

The Rand Corporation has released an impressive study showing that brand name drugs cost far more in the United States than in other countries – on average 344% more. For those of you looking for a methodologically strong analysis of international drug prices and a history of related studies, this is the report for you.

Branding 97

Branding Drugs Sales Generic Drugs 97

World of DTC Marketing

JUNE 22, 2022

Then there is the cost of generic drugs. A recent study in the An­nals of In­ter­nal Med­i­cine took a look at al­most 90 gener­ic drugs that the Medicare Part D pro­gram pays for, find­ing that Medicare could’ve saved $3.6 bil­lion in 2020 if it had pur­chased 77 of 89 drugs from Cuban’s firm.

Pharmacy 227

Pharmacy Generic Drugs Life Science Branding 227

NY Times

SEPTEMBER 18, 2021

Competition for market share at rock-bottom prices has led to shortages, price-spikes, allegations of price-fixing, and substandard and even dangerous practices.

Generic Drugs 96

Generic Drugs Drugs Marketing Branding 96

Drug Patent Watch

JANUARY 7, 2025

Generic drugs play a crucial role in providing affordable medication options to patients. However, many individuals still harbor misconceptions and doubts about the efficacy and safety of generic alternatives. What Are Generic Drugs?

Generic Drugs 59

Generic Drugs Drugs Branding Bioequivalency 59

Drug Patent Watch

SEPTEMBER 25, 2024

Generic drug manufacturers face significant challenges when attempting to navigate around REMS (Risk Evaluation and Mitigation Strategies) imposed by brand-name drug companies. These strategies, intended to ensure drug safety, are sometimes misused to delay generic competition.

Generic Drugs 105

Generic Drugs Drugs Manufacturing Branding 105

FDA Law Blog

SEPTEMBER 25, 2024

But forty years ago, Al was the generic drug industry’s patent counsel during the negotiations that led to the Hatch-Waxman Amendments. These days, Al (as we have come to know him) is a Trustee for The Engelberg Foundation, a private foundation that supports the Icahn School of Medicine at Mt.

Generic Drugs 59

Generic Drugs Medicine Drugs Branding 59

STAT News

AUGUST 3, 2022

Civica Rx, which was formed four years ago, is working with a generic manufacturer to supply pharmacies with the abiraterone prostate cancer treatment for $160 for a month’s supply. Continue to STAT+ to read the full story…

Generic Drugs 98

Generic Drugs Pharmacy Drugs Branding 98

BioTech 365

APRIL 28, 2021

United States Drug Patent Prices Database 2021: Brand vs. Generic Drug Price Gap, find generic entry opportunities – ResearchAndMarkets.com United States Drug Patent Prices Database 2021: Brand vs. Generic Drug Price Gap, find generic entry opportunities – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The … Continue reading (..)

Generic Drugs 40

Generic Drugs Branding Drugs 40

Drug Patent Watch

NOVEMBER 12, 2024

Generic drug development is a crucial aspect of the pharmaceutical industry, providing cost-effective alternatives to brand-name medications. Here are the top 10 challenges faced by generic drug developers: Generic drug development involves navigating complex regulatory frameworks, including the U.S.

Generic Drugs 105

Generic Drugs Development Drugs Branding 105

Pharmacy Checkers

JULY 11, 2019

I’m proud to share that PharmacyChecker has published a white paper that examines prices and availability of newly approved generic drugs. Our report, based on 40 generic medications that were approved from 2017-2018, clearly shows that generic drug approvals often don’t lead to greater affordability or even access here in the U.S.

Generic Drugs 48

Generic Drugs FDA Approval Drugs Branding 48

World of DTC Marketing

AUGUST 7, 2022

Once limited to a few new treatments, it’s now being applied widely, even to generic drugs and established regimens.?The Medicare drug insurance is a product of compromise after decades of debate in Congress. Generic drugs may also be cheaper with a coupon than your drug insurance. The result:?

Doctor 263

Doctor Doctors Generic Drugs Drugs 263

Drug Patent Watch

DECEMBER 26, 2024

However, the high cost of prescription drugs remains a significant barrier to access for many patients. One key solution to this issue lies in the role of generic drugs, which are significantly cheaper than branded products and can help reduce the financial burden on patients and the healthcare system.

Medicine 98

Medicine Generic Drugs Branding Engineer 98

Scienmag

JUNE 15, 2022

MINNEAPOLIS – The cost of brand-name drugs for epilepsy increased by 277% from 2010 to 2018, according to a study published in the June 15, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.The cost of generic drugs for epilepsy decreased by 42% over the same period.

Branding 57

Branding Generic Drugs Drugs 57

STAT News

JANUARY 24, 2023

users with a new prescription benefit called RxPass, which will allow Prime members to get as many drugs as they need for $5 a month from a list of 50 generic medications used to treat more than 80 common conditions , CNBC tells us. Amazon … Amazon is beefing up its Prime program for U.S.

Generic Drugs 98

Generic Drugs Pharmacy Drugs Branding 98

Pharmaceutical Technology

OCTOBER 5, 2008

’ Generic drug renaissance Shionogi’s acquisition of Sciele was partly due to the US business experience of Shionogi’s chief executive, Isao Teshirogi. ” The move, which came in June, also gives Japanese drugs maker Daiichi Sankyo a foothold in the Indian market through Ranbaxy’s location. .”

Generic Drugs 100

Generic Drugs Marketing Branding Drugs 100

Pharmaceutical Technology

JULY 25, 2022

Unlike biosimilars, it is simpler for small molecule specialty generics to establish equivalence to their branded forms, explains Vasquez. Watanabe refers to the example of Teva’s immunomodulator drug Copaxone used for the treatment of multiple sclerosis, which the company produced and marketed as its own branded product.

Drugs 298

Drugs Manufacturing Production Marketing 298

STAT News

MARCH 16, 2023

regulators approved dozens of inhalers to treat asthma and chronic obstructive pulmonary disease over a recent 15-year period, but a new study found that generic companies have only twice successfully pursued an established pathway to create lower-cost, rival products.

Generic Drugs 105

Generic Drugs Branding Regulation Manufacturing 105

World of DTC Marketing

JULY 27, 2022

A drug’s out-of-pocket cost is primarily the result of decisions made by insurance companies and pharmacy benefit managers (PBMs). In 2021 pharma provided a staggering $204 billion in price concessions for brand-name medicines to PBMs. Insurers and PBMs have even devised schemes to overcharge patients for generic drugs.

Pharmacy 226

Pharmacy Generic Drugs Medicine Drugs 226

Drug Channels

OCTOBER 18, 2022

Below, we share our estimates for wholesalers’ gross margins for brand-name, generic, and biosimilar drugs. We then explain the channel dynamics behind biosimilar and generic drugs’ profits. We estimate that for 2022, generics and biosimilars accounted for only about 15% of wholesalers’ U.S.

Drugs 97

Drugs Generic Drugs Branding Sales 97

Pharmacy Checkers

FEBRUARY 14, 2020

Years ago, they took on the Food and Drug Administration in regards to Budeprion XL distributed by Teva Pharmaceuticals, the supposed generic equivalent to the popular antidepressant, Wellbutrin XL. Many readers complained that it just wasn’t cutting it compared to the brand name version. Just switch back to the brand!”

Branding 62

Branding FDA Approval Pharmacy Bioequivalency 62

World of DTC Marketing

DECEMBER 18, 2020

were dispensed using generic drugs. When both brand and generic versions of the prescribed medication were available, the generic was chosen 97 percent of the time, resulting in significant patient savings. healthcare system saved almost $2 trillion from 2009 to 2019 in healthcare costs due to generic drugs.

Generic Drugs 155

Generic Drugs Drugs Pharma Companies Vaccine 155

BioTech 365

OCTOBER 28, 2020

DUBLIN–(BUSINESS WIRE)–The “Drug Patent Database Subscription: US Drug Prices” database has been added to ResearchAndMarkets.com’s offering. This subscription was created to answer a simple question: When do drug patents expire? Your needs evolve as the industry keeps changing.

Generic Drugs 40

Generic Drugs Branding Drugs 40

Pharmaceutical Technology

OCTOBER 28, 2022

To demonstrate bioequivalence for a generic small molecule drug, a company must carry out a Phase I clinical trial in healthy individuals to ensure that the area under the curve and maximum plasma concentration for their drug is equivalent to that of the brand name drug.

Bioequivalency 130

Bioequivalency Production Contamination Branding 130

XTalks

MARCH 15, 2024

It also introduced a feature that allows users to use coupons at checkout to get manufacturer discounts on brand name medications. Amazon Pharmacy says it is focused on transparent pricing and affordability of both branded and generic drugs.

Pharmacy 111

Pharmacy Drugs Insulin Branding 111

FDA Law Blog

NOVEMBER 16, 2021

While this blogger does not have any particular comments on whether or not the idea of government drug price negotiation is good or bad, the way it has been structured in H.R. 5376 appears to have been without regard to the generic drug an biosimilar biological product industries.

Generic Drugs 52

Generic Drugs Manufacturing Drugs Licensing 52

pharmaphorum

JUNE 6, 2022

MCCPDC bypasses the “middlemen” by working directly with distributors and manufacturers to offer generic drugs at decreased costs. We want to work with every source of medications, branded or generic.” “And, of course, Truepill, who does our prescription fulfilment.”

Drugs 144

Drugs Manufacturing Pharmacy Branding 144

World of DTC Marketing

JANUARY 31, 2021

So where to start… Congresswoman Porter may want to look at the percentage of generic drugs available virus branded (89%). I have worked with and stayed in contact with some R&D people within pharma and they have a different answer. Most common health conditions already have medications to treat them.

In-Vivo 187

In-Vivo Generic Drugs Drugs Gene Therapy 187

Pharmaceutical Technology

SEPTEMBER 15, 2022

Various factors have contributed to the need and growth of API chemical suppliers such as rising healthcare expenditure, increasing disposable incomes, growing geriatric population, increasing incidence of chronic diseases, patent expiration of blockbuster drugs, increased consumption of generic drugs, and intervention of the new generation APIs.

Marketing 100

Marketing Manufacturing Generic Drugs Containment 100

Pharmaceutical Technology

FEBRUARY 24, 2023

A leaked draft (see below) of the legislation, whose final version will be published next month, proposes reducing market exclusivity time by one year for most branded drugs, although it would extend exclusivity for certain drugs for unmet needs.

Regulation 162

Regulation Clinical Trials Clinical Trials Medicine 162

Pharmaceutical Technology

NOVEMBER 29, 2022

The treatment, sold under the brand name Spravato by Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson , is also indicated for the treatment of depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal thoughts. Moreover, securing funding is a significant challenge, says Schwenk.

Research 275

Research Trials Drugs Generic Drugs 275